NO20054124L - Dyre-fri celle kultur metode - Google Patents
Dyre-fri celle kultur metodeInfo
- Publication number
- NO20054124L NO20054124L NO20054124A NO20054124A NO20054124L NO 20054124 L NO20054124 L NO 20054124L NO 20054124 A NO20054124 A NO 20054124A NO 20054124 A NO20054124 A NO 20054124A NO 20054124 L NO20054124 L NO 20054124L
- Authority
- NO
- Norway
- Prior art keywords
- cell culture
- animal
- relates
- animal origin
- culture method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32451—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0304799.0A GB0304799D0 (en) | 2003-03-03 | 2003-03-03 | Novel method |
| PCT/EP2004/002067 WO2004078955A1 (en) | 2003-03-03 | 2004-03-01 | Animal-free cell culture method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054124D0 NO20054124D0 (no) | 2005-09-05 |
| NO20054124L true NO20054124L (no) | 2005-09-27 |
Family
ID=9953995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054124A NO20054124L (no) | 2003-03-03 | 2005-09-05 | Dyre-fri celle kultur metode |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8034617B2 (pt) |
| EP (3) | EP2186885A1 (pt) |
| JP (2) | JP4787739B2 (pt) |
| KR (1) | KR101242090B1 (pt) |
| CN (2) | CN101200705A (pt) |
| AU (1) | AU2004217807B2 (pt) |
| BR (1) | BRPI0407636A (pt) |
| CA (1) | CA2517327A1 (pt) |
| CO (1) | CO5601047A2 (pt) |
| GB (1) | GB0304799D0 (pt) |
| IS (1) | IS7992A (pt) |
| MA (1) | MA27631A1 (pt) |
| MX (1) | MXPA05009096A (pt) |
| NO (1) | NO20054124L (pt) |
| NZ (1) | NZ541908A (pt) |
| RU (1) | RU2369634C2 (pt) |
| WO (1) | WO2004078955A1 (pt) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2403357T3 (es) | 2003-12-11 | 2013-05-17 | Isto Technologies Inc. | Sistema de cartílago particulado |
| US8221969B2 (en) | 2004-04-19 | 2012-07-17 | Sanyo Chemical Industries, Ltd. | Method of producing virus |
| JP2008518597A (ja) * | 2004-10-29 | 2008-06-05 | セントカー・インコーポレーテツド | 化学的規定培地組成物 |
| WO2006095431A1 (ja) * | 2005-03-10 | 2006-09-14 | Kyoritsu Seiyaku Corporation | 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法 |
| CA2610315A1 (en) * | 2005-06-03 | 2006-12-07 | Biovitrum Ab (Publ) | Process for cultivating animal cells comprising the feeding of plant-derived peptones |
| JP5292533B2 (ja) | 2005-08-26 | 2013-09-18 | ジンマー・インコーポレイテッド | インプラントおよび関節疾患の治療、置換および治療方法 |
| EP1764117A1 (en) | 2005-09-20 | 2007-03-21 | Zimmer GmbH | Implant for the repair of a cartilage defect and method for manufacturing the implant |
| US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
| US20090012629A1 (en) | 2007-04-12 | 2009-01-08 | Isto Technologies, Inc. | Compositions and methods for tissue repair |
| FI20075417A0 (fi) * | 2007-06-05 | 2007-06-05 | Marjo-Riitta Suuronen | Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen |
| DK2250251T3 (en) | 2008-01-09 | 2018-01-22 | Sartorius Stedim Cellca Gmbh | Improved culture medium additive and method of using it |
| AR075437A1 (es) | 2009-02-17 | 2011-03-30 | Glaxosmithkline Biolog Sa | Composicion inmunogenica que comprende al menos un antigeno del virus del dengue inactivado y un adyuvante sin aluminio, metodo para producir dicha vacuna y su uso para preparar un medicamento |
| ES2533074T3 (es) | 2010-04-26 | 2015-04-07 | Novartis Ag | Medio de cultivo celular mejorado |
| CN101831415B (zh) * | 2010-05-12 | 2012-05-30 | 江苏博立生物制品有限公司 | 一种提高糖化酶发酵水平的方法 |
| KR102351944B1 (ko) * | 2011-02-28 | 2022-01-18 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 세포 배양 시스템 |
| WO2013084190A1 (en) | 2011-12-08 | 2013-06-13 | Yeda Research And Development Co. Ltd. | Mammalian fetal pulmonary cells and therapeutic use of same |
| US9493744B2 (en) | 2012-06-20 | 2016-11-15 | Genentech, Inc. | Methods for viral inactivation and other adventitious agents |
| US20130281355A1 (en) * | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
| JP6041199B2 (ja) * | 2012-09-14 | 2016-12-07 | 国立大学法人大阪大学 | 三次元細胞培養体の製造方法 |
| US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
| ES2917884T3 (es) | 2015-06-18 | 2022-07-12 | Yeda Res & Dev | Protocolos de acondicionamiento y uso de los mismos para la regeneración de tejidos |
| US10004795B2 (en) * | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
| BE1024160B9 (fr) | 2015-12-22 | 2017-12-06 | Glaxosmithkline Biologicals Sa | Formulation immunogène |
| CN105567628B (zh) * | 2016-01-30 | 2019-07-12 | 令世鑫 | 一种全悬浮培养mdck细胞的低血清培养基 |
| CN105695393B (zh) * | 2016-03-24 | 2019-09-10 | 友康恒业生物科技（北京）有限公司 | 一种mdck细胞无血清培养基及其用途和制备 |
| CN105779376B (zh) * | 2016-03-24 | 2019-08-30 | 友康恒业生物科技（北京）有限公司 | 一种流感病毒分离无血清培养基及其用途和制备 |
| KR101925079B1 (ko) * | 2017-05-24 | 2018-12-04 | 가천대학교 산학협력단 | Dna 정제-증폭을 위한 통합형 마이크로 디바이스 및 이를 이용한 dna 정제-증폭 방법 |
| CN107432931B (zh) * | 2017-08-03 | 2018-04-13 | 长春祈健生物制品有限公司 | 一种微载体培养水痘病毒制备疫苗的方法 |
| BR112021014116A2 (pt) * | 2019-01-17 | 2021-09-21 | Boehringer Ingelheim Animal Health USA Inc. | Meio sem soro para produção de vacinas aviárias e seus usos |
| CN113373107B (zh) * | 2021-01-29 | 2022-12-30 | 上海生物制品研究所有限责任公司 | 一种大规模制备传代鸡胚细胞生产病毒的方法 |
| WO2024039216A1 (ko) * | 2022-08-19 | 2024-02-22 | 셀미트주식회사 | 동물세포 또는 동물 세포주의 배양방법 |
| CN115627255B (zh) * | 2022-12-01 | 2023-04-07 | 天信和(苏州)生物科技有限公司 | 一种采用低血清培养基培养人二倍体细胞的方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL94611A (en) * | 1989-06-05 | 1994-12-29 | Organogenesis Inc | Medium for cell cultures containing insulin or growth factor similar to insulin, transferrin or iron ion, triiodothyronine or thyroxine and method of use |
| GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| DE4115722A1 (de) | 1991-05-14 | 1992-11-19 | Boehringer Mannheim Gmbh | Serumfreies medium zur kultivierung von saeugerzellen |
| DZ1706A1 (fr) * | 1992-08-07 | 2002-02-17 | Merck & Co Inc | Vaccin contre le virus de l'hepatite a. |
| SG73999A1 (en) | 1992-09-18 | 2000-07-18 | Us Health | Hepatitis a virus vaccines |
| CN1088984A (zh) * | 1993-11-11 | 1994-07-06 | 江西省医学科学研究所 | 一种用于造血祖细胞培养的无血清培养基 |
| HRP950097A2 (en) | 1994-03-08 | 1997-06-30 | Merck & Co Inc | Hepatitis a virus culture process |
| WO1996015231A2 (en) | 1994-11-10 | 1996-05-23 | Immuno Aktiengesellschaft | Method for producing biologicals in protein-free culture |
| WO1998000521A1 (fr) * | 1996-06-28 | 1998-01-08 | The Green Cross Corporation | Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives |
| WO1998004680A1 (en) * | 1996-07-26 | 1998-02-05 | University Of Manitoba | Serum-free medium for growth of anchorage-dependant mammalian cells |
| US6103529A (en) * | 1996-10-10 | 2000-08-15 | Life Technologies, Inc. | Animal cell culture media comprising peptides derived from rice |
| AU7984498A (en) * | 1997-06-25 | 1999-01-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Serum-free cell growth medium |
| US6656719B1 (en) * | 1997-10-27 | 2003-12-02 | Merck & Co., Inc. | Serum-free, low-protein media for rotavirus vaccine production |
| FR2775983B1 (fr) | 1998-03-13 | 2000-11-10 | Pasteur Merieux Serums Vacc | Milieu et procede de propagation et de multiplication virales |
| WO1999057246A1 (en) | 1998-05-01 | 1999-11-11 | Life Technologies, Inc. | Animal cell culture media comprising non-animal or plant-derived nutrients |
| US6406909B1 (en) * | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| US6623959B2 (en) * | 2001-06-13 | 2003-09-23 | Ethicon, Inc. | Devices and methods for cell harvesting |
-
2003
- 2003-03-03 GB GBGB0304799.0A patent/GB0304799D0/en not_active Ceased
-
2004
- 2004-03-01 BR BRPI0407636-2A patent/BRPI0407636A/pt not_active IP Right Cessation
- 2004-03-01 EP EP10151350A patent/EP2186885A1/en not_active Withdrawn
- 2004-03-01 MX MXPA05009096A patent/MXPA05009096A/es active IP Right Grant
- 2004-03-01 CA CA002517327A patent/CA2517327A1/en not_active Abandoned
- 2004-03-01 KR KR1020057016385A patent/KR101242090B1/ko not_active IP Right Cessation
- 2004-03-01 CN CNA2007101866779A patent/CN101200705A/zh active Pending
- 2004-03-01 JP JP2006504501A patent/JP4787739B2/ja not_active Expired - Fee Related
- 2004-03-01 NZ NZ541908A patent/NZ541908A/en unknown
- 2004-03-01 RU RU2005125606/13A patent/RU2369634C2/ru not_active IP Right Cessation
- 2004-03-01 WO PCT/EP2004/002067 patent/WO2004078955A1/en active Application Filing
- 2004-03-01 EP EP04715891A patent/EP1599580A1/en not_active Ceased
- 2004-03-01 CN CN2004800058488A patent/CN1756837B/zh not_active Expired - Fee Related
- 2004-03-01 EP EP10151351A patent/EP2192175A1/en not_active Ceased
- 2004-03-01 AU AU2004217807A patent/AU2004217807B2/en not_active Ceased
- 2004-03-01 US US10/547,804 patent/US8034617B2/en not_active Expired - Fee Related
-
2005
- 2005-08-18 IS IS7992A patent/IS7992A/is unknown
- 2005-08-31 CO CO05087280A patent/CO5601047A2/es not_active Application Discontinuation
- 2005-09-05 NO NO20054124A patent/NO20054124L/no not_active Application Discontinuation
- 2005-09-09 MA MA28488A patent/MA27631A1/fr unknown
-
2010
- 2010-07-12 JP JP2010157682A patent/JP2010273683A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2192175A1 (en) | 2010-06-02 |
| AU2004217807A1 (en) | 2004-09-16 |
| RU2005125606A (ru) | 2006-03-10 |
| US8034617B2 (en) | 2011-10-11 |
| WO2004078955A1 (en) | 2004-09-16 |
| BRPI0407636A (pt) | 2006-02-21 |
| MA27631A1 (fr) | 2005-11-01 |
| KR101242090B1 (ko) | 2013-03-08 |
| US20060183224A1 (en) | 2006-08-17 |
| CA2517327A1 (en) | 2004-09-16 |
| EP1599580A1 (en) | 2005-11-30 |
| CO5601047A2 (es) | 2006-01-31 |
| GB0304799D0 (en) | 2003-04-09 |
| JP4787739B2 (ja) | 2011-10-05 |
| CN101200705A (zh) | 2008-06-18 |
| CN1756837B (zh) | 2010-05-26 |
| CN1756837A (zh) | 2006-04-05 |
| MXPA05009096A (es) | 2005-10-19 |
| NO20054124D0 (no) | 2005-09-05 |
| RU2369634C2 (ru) | 2009-10-10 |
| KR20050105509A (ko) | 2005-11-04 |
| IS7992A (is) | 2005-08-18 |
| JP2006519023A (ja) | 2006-08-24 |
| JP2010273683A (ja) | 2010-12-09 |
| AU2004217807B2 (en) | 2009-06-25 |
| NZ541908A (en) | 2008-04-30 |
| EP2186885A1 (en) | 2010-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054124L (no) | Dyre-fri celle kultur metode | |
| MX2007005132A (es) | Medios libres de proteina animal para cultivo de celulas. | |
| ES2526191T3 (es) | Método para producir virus influenza B infeccioso en cultivo celular | |
| ATE469972T1 (de) | Multiplasmid-system zur erzeugung des grippevirus | |
| NO20051175L (no) | Fremgangsmate til fremstilling av primaere celler og til amplifikasjon av vira under serumfrie betingelser | |
| CN101194012A (zh) | 在悬浮的禽类胚胎衍生的干细胞中制备病毒疫苗的方法 | |
| FR08C0046I2 (fr) | Reconstitution in vitro de virus a arn de polarite negative segmentes | |
| RU2008106445A (ru) | Вирусоподобные корпускулы (частицы) в качестве противопарамиксовирусной вакцины | |
| MX2009002741A (es) | Lineas de celulas mdck que soportan el crecimiento viral para altos titulos y proceso de biorreactor que utiliza las mismas. | |
| ATE549395T1 (de) | Medium und kultur von embryonalen stammzellen | |
| WO2007048089A3 (en) | Multi-plasmid system for the production of influenza virus | |
| AR077314A1 (es) | Produccion de titulos elevados de poliovirus para la produccion de vacunas | |
| DK1201749T3 (da) | Fremgangsmåde til fremstilling af humane bruskimplantater ved hjælp af in vitro dyrkede chondrocytter | |
| WO2005115448A3 (en) | Multi plasmid system for the production of influenza virus | |
| CY1111253T1 (el) | Μεθοδος για την παραγωγη ιικου υλικου | |
| RU2012130928A (ru) | Способ культивирования адгезионных клеток | |
| AR069885A1 (es) | Metodos para producir el virus de estomatitis vesicular (vsv) atenuado en un cultivo celular y para mejorar el empaque del vsv de propagacion defectuosa, composicion inmunogenica, celula aislada y secuencia de control transcripcional | |
| CN105052746A (zh) | 一种紫锥菊不定芽再生培养方法 | |
| EP1739167A4 (en) | METHOD OF PRODUCING VIRUSES | |
| DK1334197T3 (da) | Gær-afledt vaccine mod IPNV | |
| AR069884A1 (es) | Metodos para empacar vectores de virus de estomatitis vesicular de propagacion defectuosa | |
| ATE511397T1 (de) | Lungenzellen von baumwollratten zur virenkultur | |
| ATE486124T1 (de) | Keratinozyten-kulturverfahren und verwendung davon | |
| RU2009144970A (ru) | Двухстадийный температурный профиль культивирования вирусов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |